
|

| |
Track the *RXPAI Index |
 |
|
 | Pain Management Stocks (*RXPAI) |
| |
Pain Management Ideas |
|
|
|
Pain Management Performance |
|
|
|
Pain Management Community |
|
| |
|
Index Description: These medical firms have significant exposure to the growing field of pain management
|
|
|
|
|
Today:
1-month:
All-time:
|
+0.3%
+4.3%
+96.6%
|
vs S&P 500:
vs S&P 500:
vs S&P 500:
|
+0.6%
-0.3%
+77.1%
|
Avg. Market Cap:
Avg. P/E Ratio:
Avg. Div Yield:
|
$548.9M
14.4
0.0%
|
|
|
|
|
Share this Index on Facebook
Share this Index on Twitter
|
|
| |
|
|
|
|
|
|
|
|
|
|
| |
|
| |

Click
a column to sort | Scroll over columns for more information |
|
|
| ACRX |
$7.93 |
+0.48 |
+6.4% |
477,197 |
129% |
$277.4M |
- |
249% |
4% |
3 Alerts (0 News) - View
|
|
|
| ACUR |
$2.35 |
-0.01 |
-0.3% |
124,583 |
12% |
$109.4M |
- |
122% |
-48% |
No Alerts/News
|
|
|
| CPIX |
$4.90 |
+0.15 |
+3.2% |
44,838 |
104% |
$88.1M |
- |
22% |
-28% |
No Alerts/News
|
|
|
| DRRX |
$0.87 |
-0.02 |
-2.4% |
83,727 |
10% |
$90.6M |
- |
42% |
-53% |
1 Alert (0 News) - View
|
|
|
| ENDP |
$33.88 |
-0.40 |
-1.2% |
481,897 |
19% |
$3.8B |
- |
35% |
-12% |
No Alerts/News
|
|
|
| HZNP |
$2.39 |
0.00 |
0.0% |
121,119 |
39% |
$148.0M |
- |
22% |
-73% |
No Alerts/News
|
|
|
| OMER |
$5.21 |
+0.13 |
+2.6% |
68,784 |
28% |
$131.6M |
- |
43% |
-61% |
No Alerts/News
|
|
|
| PATH |
$3.19 |
+0.08 |
+2.6% |
83,919 |
57% |
$90.4M |
- |
29% |
-31% |
No Alerts/News
|
|
|
| PCRX |
$29.10 |
-0.63 |
-2.1% |
150,086 |
41% |
$979.8M |
- |
194% |
-6% |
No Alerts/News
|
|
|
| PTIE |
$2.80 |
-0.06 |
-2.1% |
134,186 |
24% |
$129.6M |
- |
20% |
-52% |
No Alerts/News
|
|
|
| ZGNX |
$1.54 |
-0.03 |
-1.9% |
134,041 |
21% |
$158.2M |
- |
39% |
-53% |
No Alerts/News
|
|
|
|
Is this index incomplete or incorrect?
Got an idea for a new Index?
|
|
|
| |

|
| |
|
| |

|
| |
NuPathe Announces First Quarter 2013 Financial Results and Operational Highlights PATH
Linked by marketwire ( track newsfeed | ignore newsfeed ) - May 14, 07:30AM from (www2.marketwire.com) NuPathe Inc. (NASDAQ: PATH) today announced financial results for the quarter ended March 31, 2013, as well as recent operational
Flag
Post a comment
FDA Not Buying Endo Health’s Painkiller Ploy ENDP
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - May 13, 08:54AM from (ycharts.com) In a sharp rebuff to Endo Health Solutions (ENDP), the FDA has denied a citizen petition that the drugmaker had filed last
Flag
Post a comment
Blue Ridge Capital Starts Endo Health Solutions Position ENDP
Linked by market folly ( track newsfeed | ignore newsfeed ) - May 10, 02:51PM from (www.marketfolly.com) John Griffin's hedge fund firm Blue Ridge Capital filed a 13G with the SEC and just disclosed a 5.98% ownership stake in Endo Health Solutions (ENDP) with 6,635,000 shares.
Flag
Post a comment
Six Hot Stocks to Watch for Friday: Gap, 3D Systems, Pain Therapeutics and More GPS PGNX DDD PTIE SQNM UBNT
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 10, 09:20AM from (247wallst.com) It is Friday, so TGIF. Before you get too deep into your weekend there is still a full trading day and Wall Street has many
Flag
Post a comment
Horizon Pharma Announces First Quarter 2013 Financial Results and Provides Business Update HZNP
Linked by marketwire ( track newsfeed | ignore newsfeed ) - May 10, 06:30AM from (www2.marketwire.com) Horizon Pharma, Inc. (NASDAQ: HZNP) today provided an update on the Company's business and announced financial results for
Flag
Post a comment
Pain Therapeutics Files Form 8-K Regarding Correspondence From Pfizer, Inc. PFE PTIE
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 10, 06:13AM from (globenewswire.com) AUSTIN, Texas, May 10, 2013 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) announced today that yesterday it received
Flag
Post a comment
Zogenix Announces Conference Call and Webcast to Present First Quarter 2013 Financial Results ZGNX
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 03, 07:43AM from (globenewswire.com) SAN DIEGO, May 3, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing
Flag
Post a comment
Acura Pharmaceuticals Announces First Quarter 2013 Financial Results ACUR
Linked by marketwire ( track newsfeed | ignore newsfeed ) - May 02, 04:10PM from (www2.marketwire.com) Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication
Flag
Post a comment
|
|
|